While this supports weight loss goals, it may also reduce your desire to eat adequate fuel for physical activity
These are very effective medications as a tool to lose weight, he said
Across multiple studies in both diabetes and obesity populations, GLP-1 receptor agonists consistently improved mental health-related quality of life compared to placebo
A 2021 analysis published in Cardiovascular Diabetology found that semaglutide produced significant reductions in triglycerides and total cholesterol alongside its weight loss effects, with improvements correlating strongly with the degree of weight lost (Husain et al., Cardiovascular Diabetology, 2021, Tirzepatide and Cholesterol: Does the Dual Mechanism Help More For patients with significant lipid abnormalities, tirzepatide may offer an advantage over semaglutide
One potential mechanism could be increased prevalence of NAION risk factors in patients starting GLP-1RA or that sudden and rapid decline in blood glucose could increase the risk of diabetic papillopathy or worsened DR
Pharmaceutical companies and non-profit organizations offer these programs, as do certain government agencies and other third parties
